{
    "eid": "2-s2.0-85090219351",
    "title": "Ccl-11 or eotaxin-1: An immune marker for ageing and accelerated ageing in neuro-psychiatric disorders",
    "cover-date": "2020-09-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Molecular Medicine",
            "@code": "1313",
            "@abbrev": "BIOC"
        },
        {
            "@_fa": "true",
            "$": "Pharmaceutical Science",
            "@code": "3003",
            "@abbrev": "PHAR"
        }
    ],
    "keywords": [
        "Aging",
        "Alzheimer\u2019s disease",
        "Behaviour",
        "Biomarkers",
        "Brain",
        "CCL-11",
        "Cytokines",
        "Eotaxin",
        "Prevention",
        "Schizophrenia",
        "Stroke"
    ],
    "authors": [
        "Mariya Ivanovska",
        "Zakee Abdi",
        "Marianna Murdjeva",
        "Danielle Macedo",
        "Annabel Maes",
        "Michael Maes"
    ],
    "citedby-count": 26,
    "ref-count": 93,
    "ref-list": [
        "Multistep navigation and the combinatorial control of leukocyte chemotaxis",
        "International union of pharmacology. XXII. Nomenclature for chemokine receptors",
        "Traffic signals for lymphocyte recirculation and leukocyte emigration: The multistep paradigm",
        "Purification and characterization of human and bovine platelet factor 4",
        "Chemokines and chemokine receptors in the brain: Implication in neuroendocrine regulation",
        "Do chemokines mediate inflammatory cell invasion of the central nervous system parenchyma?",
        "Current status of chemokines in the adult CNS",
        "Revisiting the Role of Eotaxin-1/CCL11 in Psychiatric Disorders",
        "A new schizophrenia model: Immune activation is associated with induction of different neurotoxic products which together determine memory impairments and schizophrenia symptom dimensions",
        "CCL11, a novel mediator of inflammatory bone resorption",
        "Eotaxin, an Endogenous Cognitive Deteriorating Chemokine (ECDC), Is a Major Contributor to Cognitive Decline in Normal People and to Executive, Memory, and Sustained Attention Deficits, Formal Thought Disorders, and Psychopathology in Schizophrenia Patients",
        "The ageing systemic milieu negatively regulates neurogenesis and cognitive function",
        "Expression of specific chemokines and chemokine receptors in the central nervous system of multiple sclerosis patients",
        "Neuroplastic changes in depression: A role for the immune system",
        "Knockout of CXCR5 increases the population of immature neural cells and decreases proliferation in the hippocampal dentate gyrus",
        "CNS-specific immunity at the choroid plexus shifts toward destructive Th2 inflammation in brain aging",
        "Monocyte chemoattractant protein-2 can exert its effects through the MCP-1 receptor (CC CKR2B)",
        "Eotaxin: A potent eosinophil chemoattractant cytokine detected in a guinea pig model of allergic airways inflammation",
        "Molecular cloning and characterization of a human eotaxin receptor expressed selectively on eosinophils",
        "Selective expression of the eotaxin receptor CCR3 by human T helper 2 cells",
        "Asthma, allergy and chemokines",
        "The CC chemokine eotaxin (CCL11) is a partial agonist of CC chemokine receptor 2b",
        "Eotaxin is a natural antagonist for CCR2 and an agonist for CCR5",
        "Binding and functional properties of recombinant and endogenous CXCR3 chemokine receptors",
        "Role of eotaxin in the pathophysiology of asthma",
        "IL-37 inhibitsIL-4/IL-13-induced CCL11 production and lung eosinophilia in murine allergic asthma",
        "Eotaxins and CCR3 receptor in inflammatory and allergic skin diseases: Therapeutical implications",
        "Eotaxin receptor (CCR3) antagonism in asthma and allergic disease",
        "Chapter-2 Eosinophil Cytokines in Allergy",
        "Cytokines and chemoattractants in allergic inflammation",
        "New chemokine targets for asthma therapy",
        "Chemokine receptor antagonists: A novel therapeutic approach in allergic diseases",
        "Rapid transport of CCL11 across the blood-brain barrier: Regional variation and importance of blood cells",
        "Eotaxin increases monolayer permeability of human coronary artery endothelial cells",
        "Breakdown of the paracellular tight and adherens junctions in the gut and blood brain barrier and damage to the vascular barrier in patients with deficit schizophrenia",
        "CCL11 enhances excitotoxic neuronal death by producing reactive oxygen species in microglia",
        "Targeting CCR3 to Reduce Amyloid-\u03b2 Production, Tau Hyperphosphorylation, and Synaptic Loss in a Mouse Model of Alzheimer\u2019s Disease",
        "Immunohistochemical study of the beta-chemokine receptors CCR3 and CCR5 and their ligands in normal and Alzheimer\u2019s disease brains",
        "The \"aging factor\" eotaxin-1 (ccl11) is detectable in transfusion blood products and increases with the donor\u2019s age",
        "An emerging role for eotaxins in neurodegenerative disease",
        "Association between plasma CCL11 (eotaxin-1) and cognitive status in older adults: Differences between rural and urban dwellers",
        "Plasma-soluble interleukin-2 and transferrin receptor in schizophrenia and major depression",
        "Effects of risperidone on cytokine profile in drug-na\u00efve first-episode psychosis",
        "Depression, cytokine, and cytokine by treatment interactions modulate gene expression in antipsychotic na\u00efve first episode psychosis",
        "The uterine-chemokine-brain axis: Menstrual cycle-associated symptoms (mcas) are in part mediated by CCL2, CCL5, CCL11, CXCL8 and CXCL10",
        "Abnormalities in chemokine levels in schizophrenia and their clinical correlates hhs public access",
        "Telomere length and CCL11 levels are associated with gray matter volume and episodic memory performance in schizophrenia: Evidence of pathological accelerated aging",
        "High predictive value of immune-inflammatory biomarkers for schizophrenia diagnosis and association with treatment resistance",
        "Profiling inflammatory signatures of schizophrenia: A cross-sectional and meta-analysis study",
        "The neuroimmune and neurotoxic fingerprint of major neurocognitive psychosis or deficit schizophrenia: A supervised machine learning study",
        "High mobility group protein 1 and dickkopf-related protein 1 in schizophrenia and treatment-resistant schizophrenia: Associations with interleukin-6, symptom domains, and neurocognitive impairments",
        "Increased serum levels of CCL11/eotaxin in schizophrenia",
        "Peripheral eotaxin-1 (CCL11) levels and mood disorder diagnosis in a population-based sample of young adults",
        "Chemokines in bipolar disorder: Trait or state?",
        "Changes in cytokine and chemokine expression distinguish dysthymic disorder from major depression and healthy controls",
        "A detailed examination of cytokine abnormalities in Major Depressive Disorder",
        "Chemokines in depression in health and in inflammatory illness: A systematic review and meta-analysis",
        "Inflammatory mediators and dual depression: Potential biomarkers in plasma of primary and substance-induced major depression in cocaine and alcohol use disorders",
        "A cytokine study of adult patients with obsessive-compulsive disorder",
        "The immune response in autism: A new frontier for autism research",
        "Inflammation, neurotrophism and oxidative stress and childhood psychopathology in a large community sample",
        "Cytokine aberrations in autism spectrum disorder: A systematic review and meta-analysis",
        "Cerebrospinal fluid and serum markers of inflammation in autism",
        "Inflammatory chemokine eotaxin-1 is correlated with age in heroin dependent patients under methadone maintenance therapy",
        "Plasma Chemokines in patients with alcohol use disorders: Association of CCL11 (Eotaxin-1) with psychiatric comorbidity",
        "Serum levels of chemokines in Parkinson\u2019s disease",
        "Cerebrospinal fluid inflammatory markers in Parkinson\u2019s disease\u2014Associations with depression, fatigue, and cognitive impairment",
        "Eotaxins and C-C chemokine receptor type 3 in Parkinson\u2019s disease",
        "Induction of adaptive immunity leads to nigrostriatal disease progression in mptp mouse model of parkinson\u2019s disease",
        "Whole-genome sequencing suggests a chemokine gene cluster that modifies age atonset in familial Alzheimer\u2019s disease",
        "The age factor in Alzheimer\u2019s disease",
        "CCL2 is associated with a faster rate of cognitive decline during early stages of Alzheimer\u2019s disease",
        "Multiple sclerosis and other demyelinating diseases",
        "Epidemiology of multiple sclerosis",
        "Cerebrospinal fluid and blood cytokines as biomarkers for multiple sclerosis: A systematic review and meta-analysis of 226 studies with 13,526 multiple sclerosis patients",
        "Post-acute serum eosinophil and neutrophil-associated cytokine/chemokine profile can distinguish between patients with neuromyelitis optica and multiple sclerosis; and identifies potential pathophysiological mechanisms\u2014A pilot study",
        "Elevated plasma chemokines for eosinophils in neuromyelitis optica spectrum disorders during remission",
        "Multimarker risk stratification approach at multiple sclerosis onset",
        "Expression of Ccl11 associates with immune response modulation and protection against neuroinflammation in rats",
        "Protein of senility CCL11, \u201cprotein of juvenility\u201d GDF11 and their role in age-related pathology",
        "A blood-based biomarker panel to detect acute stroke",
        "CCL11 (Eotaxin-1) levels predict long-term functional outcomes in patients following ischemic stroke",
        "Impact of tag single nucleotide polymorphisms (snps) in ccl11 gene on risk of subtypes of ischemic stroke in xinjiang han populations",
        "Association of inflammatory gene polymorphisms with ischemic stroke in a Chinese Han population",
        "Genetic determinants in ischaemic stroke subtypes: Seven-year findings and a review",
        "Control of eotaxin-1 expression and release by resveratrol and its metabolites in culture human pulmonary artery endothelial cells",
        "A potent human anti-eotaxin1 antibody, CAT-213: Isolation by phage display and in vitro and in vivo efficacy",
        "Anti-inflammatory impact of minocycline in a mouse model of tauopathy",
        "Heparin and structurally related polymers attenuate eotaxin-1 (CCL11) release from human airway smooth muscle",
        "Glucocorticosteroids inhibit mRNA expression for eotaxin, eotaxin-2, and monocyte-chemotactic protein-4 in human airway inflammation with eosinophilia",
        "Production of the novel C-C chemokine MCP-4 by airway cells and comparison of its biological activity to other C-C chemokines",
        "Expression of eotaxin by human lung epithelial cells: Induction by cytokines and inhibition by glucocorticoids",
        "Effect of high-intensity exercise on aged mouse brain mitochondria, neurogenesis, and inflammation"
    ],
    "affiliation": [
        {
            "affiliation-city": "Plovdiv",
            "@id": "60031890",
            "affilname": "Medical University of Plovdiv",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60031890",
            "affiliation-country": "Bulgaria"
        },
        {
            "affiliation-city": "Beerse",
            "@id": "60068574",
            "affilname": "Janssen Pharmaceutica, Headquarters",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60068574",
            "affiliation-country": "Belgium"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60028190",
            "affilname": "Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Plovdiv",
            "@id": "60028132",
            "affilname": "St.George University Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028132",
            "affiliation-country": "Bulgaria"
        },
        {
            "affiliation-city": "Fortaleza",
            "@id": "60020457",
            "affilname": "Universidade Federal do Cear\u00e1",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60020457",
            "affiliation-country": "Brazil"
        },
        {
            "affiliation-city": "Geelong",
            "@id": "60018805",
            "affilname": "Deakin University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60018805",
            "affiliation-country": "Australia"
        },
        {
            "affiliation-city": "Plovdiv",
            "@id": "125070959",
            "affilname": "TCEMED",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/125070959",
            "affiliation-country": "Bulgaria"
        },
        {
            "affiliation-city": "Ribeirao Preto",
            "@id": "108042953",
            "affilname": "National Institute for Translational Medicine (INCT-TM",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/108042953",
            "affiliation-country": "Brazil"
        }
    ],
    "funding": []
}